A polyherbal formulation attenuates hyperoxaluria-induced oxidative stress and prevents subsequent deposition of calcium oxalate crystals and renal cell injury in rat kidneys

Chinese Journal of Natural Medicines

Volumn 11, Issue 5, 2013, Pages 466-471

  Bodakhe, Kiran S ^a   Namdeo, Kamta P ^a   Patra, Kartik C ^a   Machwal, Lalit ^b   Pareta, Surendra K ^a  

^a GURU GHASIDAS UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Ayurveda, polyherbal; Calcium oxalate; Ethylene glycol; Hyperoxaluria; Oxidative stress; Urolithiasis

Indexed keywords

ANTIOXIDANT; AYURVEDIC DRUG; CALCIUM OXALATE; CATALASE; CYSTONE; DRINKING WATER; ETHYLENE GLYCOL; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM EXCRETION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HYPEROXALURIA; KIDNEY INJURY; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PHOSPHATE EXCRETION; RAT; RISK FACTOR; URINARY EXCRETION; URINE PH; URINE VOLUME; UROLITHIASIS;

AYURVEDA, POLYHERBAL; CALCIUM OXALATE; ETHYLENE GLYCOL; HYPEROXALURIA; OXIDATIVE STRESS; UROLITHIASIS;

ANIMALS; CALCIUM OXALATE; CHEMISTRY, PHARMACEUTICAL; HUMANS; HYPEROXALURIA; INDIA; KIDNEY; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; UROLITHIASIS;

EID: 84890852724     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(13)60085-0     Document Type: Article

References (32)

1. Rao M, Rao MNA Protective effects of Cystone, a polyayurvedic preparation, on cisplatin-induced renal toxicity in rats [J]. J Ethnopharmacol 1998, 62(1):1-6.
2. Chauhan CK, Joshi MJ, Vaidya ADB Growth inhibition of struvite crystals in the presence of herbal extract Boerhaavia diffusa Linn [J]. Am J Infect Dis 2009, 5(3):177-186.
3. Leye A, Jaeger P, Robertson W, et al. Renal stone disease [J]. Medicine 2007, 35(8):415-419.
4. Khan SR Hyperoxaluria-induced oxidative stress and antioxidants for renal protection [J]. Urol Res 2005, 33(5):349-357.
5. Jonassen JA, Kohjimoto Y, Scheid CR, et al. Oxalate toxicity in renal cells [J]. Urol Res 2005, 33(5):329-339.
6. Rodrigo R, Bosco C Oxidative stress and protective effects of polyphenols: Comparative studies in human and rodent kidney [J]. Comp Biochem Physiol C 2006, 142(3-4):317-327.
7. Selvam R Calcium oxalate stone disease: Role of lipid peroxidation and antioxidants [J]. Urol Res 2002, 30(1):35-47.
8. Barry H Antioxidant effects: a basis for drug selection [J]. Drugs 1991, 42(2):569.
9. Himalaya herbal healthcare [Homepage on internet] India: Himalaya drug company; c2000 [cited 2011 Jan 23]. http://www.himalayahealthcare.com/products/cystone.htm.
10. Atmani F, Slimani Y, Mimouni M, et al. Effect of aqueous extract from Herniaria hirsuta L. on experimentally nephrolithiasic rats [J]. J Ethnopharmacol 2004, 95(1):87-93.
11. Mitra SK, Gopumadhavan S, Venkatarangannna MV, et al. Effect of Cystone, a herbal formulation, on glycolic acid-induced urolithiasis in rats [J]. Phytother Res 1998, 12(5):372-374.
12. Karadi RV, Gadgeb NB, Alagawadi KR, et al. Effect of Moringa oleifera Lam. root-wood on ethylene glycol induced urolithiasis in rats [J]. J Ethnopharmacol 2006, 105(1-2):306-311.
13. Pareta SK, Patra KC, Mazumder PM, et al. Aqueous extract of Boerhaavia diffusa root ameliorates ethylene glycol-induced hyperoxaluric oxidative stress and renal injury in rat kidney [J]. Pharm Biol 2001, 49(12):1224-1233.
14. Esterbauer H, Cheeseman KH Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal [J]. Methods Enzymol 1990, 186:407-421.
15. Chance B, Maehly C Assay of catalase and peroxidase [J]. Methods Enzymol 1955, 11:764-775.
16. Misra HP, Fridovich I The role of superoxide dismutase anion in the anti-oxidation of epinephrine and sample assay in superoxide dismutase [J]. J Biol Chem 1972, 247(10):3170-3175.
17. Dringen R, Hamprecht B Glutathione content as an indicator for the presence of metabolic pathways of amino acids in astroglial cultures [J]. J Neurochem 1996, 67(4):1375-1382.
18. Paglia DE, Valentine WN Studies on qualitative and quantitative characterization of erythrocytes glutathione peroxidase [J]. J Lab Clin Med 1967, 70(1):158-169.
19. Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins [J]. Methods Enzymol 1990, 186:464-478.
20. Soundararajan P, Mahesh R, Ramesh T, et al. Effect of Aerva lanata on calcium oxalate urolithiasis in rats [J]. Indian J Exp Biol 2006, 44(12):981-986.
21. Pareta SK, Patra KC, Mazumder PM, et al. Prophylactic role of Boerhaavia diffusa in ethylene glycol induced calcium oxalate urolithiasis [J]. African J Urol 2011, 17(2):28-36.
22. Varalakshmi P, Shamila Y, Latha E Effect of Crataeva nurvala in experimental urolithiasis [J]. J Ethnopharmacol 1990, 28(3):313-321.
23. Heutmann R, Lehmann A Intrarenal distribution of oxalic acid, calcium, sodium and potassium in men [J]. Eur Clin Invest 1980, 10(2):173-176.
24. Basavaraj DR, Biyani CS, Browning AJ, et al. The role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones [J]. EAU-EBU Update Ser 2007, 5(3):126-136.
25. Hackett RL, Shevock PN, Khan SR Alterations in MDCK and LLC-PK1 cells exposed to oxalate and calcium oxalate monohydrate crystals [J]. Scanning Micros 1995, 9(2):587-596.
26. Thamilselvan S, Selvam R Effect of vitamin E and mannitol on renal calcium oxalate retention in experimental nephrolithiasis [J]. Indian J Biochem Biophys 1997, 34(3):319-323.
27. Huang HS, Ma MC, Chen CF, et al. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones [J]. Urology 2003, 62(6):1123-1128.
28. Puntel RL, Roos DH, Paixao MW, et al. Oxalate modulates thiobarbituric acid reactive species (TBARS) production in supernatants of homogenates from rat brain, liver and kidney: Effect of diphenyl diselenide and diphenyl ditelluride [J]. Chem Biol Interact 2007, 165(2):87-98.
29. Thamilselvan S, Menon M Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status [J]. B J U Int 2005, 96(1):117-126.
30. Pareta SK, Patra KC, Mazumder PM, et al. Establishing the principle of herbal therapy for antiurolithiatic activity: A review [J]. J Pharmacol Toxicol 2001, 6(3):321-332.
31. Itoh Y, Yasui T, Tozawa AOK, et al. Examination of the anti-oxidative effect in renal tubular cells and apoptosis by oxidative stress [J]. Urol Res 2005, 33(4):261-264.
32. Bijarnia RK, Kaur T, Aggarwal K, et al. Modulatory effects of N-acetylcysteine on hyperoxaluric manifestations in rat kidney [J]. Food Chem Toxicol 2008, 46(6):2274-2278.